Beta Drugs Limited (NSE:BETA)

India · Delayed Price · Currency is INR

2,073.30

+20.30 (0.99%)

Last updated: Oct 1, 2026, 3:29 PM IST

Beta Drugs Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	4,102	3,848	3,624	2,957	2,271	1,838
Revenue Growth	10.14%	6.20%	22.54%	30.20%	23.54%	58.31%
Gross Profit	2,342	2,080	1,866	1,143	974.47	714.89
Operating Income	655.68	585.25	620.91	501.31	430.27	354.44
Net Income	455.86	414.83	424.19	364.37	307.19	248.28
Earnings Per Share	44.31	40.92	42.02	37.90	30.43	24.59
EPS Growth	6.77%	-2.62%	10.87%	24.55%	23.74%	111.72%

Revenue by Geography

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	3,140	2,829	2,497	1,974	1,589
Export	708.7	794.85	460.34	296.96	249.04
Total	3,848	3,624	2,957	2,271	1,838

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	1,248	1,248	1,470	286.33	191.64	173.24
Total Debt	1,478	1,478	1,381	147.11	203.32	206.03
Net Cash (Debt)	-229.59	-229.59	89.69	139.22	-11.68	-32.79
Net Cash Growth	-	-	-35.58%	-	-	-
Net Cash Per Share	-22.32	-22.65	8.88	14.48	-1.16	-3.25

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	372.86	361.44	309.3	233.83	296.28
Capital Expenditures	-	-534.82	-368.59	-116.16	-182.12	-194.28
Free Cash Flow	-	-161.96	-7.14	193.15	51.71	102
Free Cash Flow Growth	-	-	-	273.55%	-49.31%	-20.59%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	57.10%	54.04%	51.49%	38.66%	42.91%	38.89%
Operating Margin	15.99%	15.21%	17.14%	16.95%	18.95%	19.28%
Pretax Margin	14.82%	14.13%	15.72%	16.49%	18.08%	18.66%
Profit Margin	11.11%	10.78%	11.71%	12.32%	13.53%	13.51%
FCF Margin	-	-4.21%	-0.20%	6.53%	2.28%	5.55%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	46.79	28.94	45.35	32.55	19.62	21.90
P/FCF Ratio	-	-	-	61.41	116.57	53.30
PS Ratio	5.12	3.12	5.31	4.01	2.65	2.96